MAP3K7 and liver cancer: In addition, Inokuchi et al. and Betterman et al. investigated specific ablation of TAK1 in the liver of mice and found that TAK1 loss contributes to liver cancer progression [7], [8], findings that were consistent with those of the present study, indicating that TAK1 deficiency has a functional role in cancer development in a cell-context specific manner.